NEW YORK ( TheStreet) -- BioMimetic Therapeutics (Nasdaq: BMTI) hit a new 52-week low Monday as it is currently trading at $4.39, below its previous 52-week low of $4.40 with 66,579 shares traded as of 11:10 a.m. ET. Average volume has been 619,200 shares over the past 30 days. BioMimetic has a market cap of $124.8 million and is part of the health care sector and health services industry. Shares are down 64.4% year to date as of the close of trading on Friday. BioMimetic Therapeutics, Inc., a biotechnology company, engages in the development and commercialization of regenerative protein therapeutic-device combination products for the treatment of musculoskeletal injuries and conditions affecting bones, tendons, ligaments, and cartilage.
- Practice your BMTI trading strategies and win cash in our stock game.